PROXIMAGEN
LIVE

Serial Number

78723291

Owner

Proximagen Group Limited

Attorney

Frances M. Jagla

Filing Date

Sep 29, 2005

Add to watchlist:

No watchlists yet
View on USPTO

PROXIMAGEN Trademark

Serial Number: 78723291 • Registration: 3431171

PROXIMAGEN is a trademark filed by Proximagen Group Limited on September 29, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Proximagen Group Limited

Guys Campus, Kings College Hodgkin Build
London SE1 IUL , GB

Entity Type: 24

Proximagen Neuroscience Plc

Guys Campus, Kings College
London SE1 1UL , GB

Entity Type: 03

PROXIMAGEN LLC (3 trademarks)

505 NORTH HIGHWAY 169
PLYMOUTH, MN 55441

Entity Type: 16

PROXIMAGEN GROUP LTD.

GUYS CAMPUS, KINGS COLLEGE THE HODGKIN
LONDON SE1 1UL , GB

Entity Type: 24

Trademark Details

Filing Date

September 29, 2005

Registration Date

May 20, 2008

Published for Opposition

August 21, 2007

Goods & Services

[ Pharmaceutical preparations and substances, namely: analgesics; anesthetics, namely, anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics; anti-emetics; antiepileptics; antineuralgics; antipyretics; antirheumatics; antispasmodics; aphrodisiacs; cardiac, cerebral and hepatic restoratives, namely, analgesics, anti-virals, and anti-inflammatories; cardiac sedatives; cardiac stimulants; cerebral depressants; cerebral stimulants; depressants; digestives; diuretics; emetics; hypnotics; motor depressants; motor excitants, namely, amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines; narcotics; nervines; respiratory depressants; respiratory stimulants; sedatives; soporifics, namely, sedatives; stimulants, namely, appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants; vaso-constrictors; vasodilators; and vascular sedatives; and pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control ]

Information services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives, soporifics, namely sedatives, stimulants, namely appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants, vaso-constrictors, vasodilators, and vascular sedatives; Treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, neurostimulants, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives; Medical testing and diagnostic services; Provision of medical and pharmaceutical information; and Medical and pharmaceutical consultation

Pharmaceutical research and development services; Product research and development services; Research and development of vaccines and medicines; Research services for others in the fields of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; evaluation and testing of compounds for medical purposes, namely analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives, soporifics, namely sedatives, stimulants, namely appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants, vaso-constrictors, vasodilators, and vascular sedatives in the fields of Research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Licensing of intellectual property; Information services in relation to the fields of research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in the fields of research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 17, 2021 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 8, 2018 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 7, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 7, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 7, 2018 89AG
TEAS SECTION 8 & 9 RECEIVED
Aug 3, 2018 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 20, 2017 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 5, 2014 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 5, 2014 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 4, 2014 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
May 20, 2014 815F
TEAS SECTION 8 & 15 RECEIVED
May 20, 2014 E815
REGISTERED-PRINCIPAL REGISTER
May 20, 2008 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Apr 14, 2008 DP1B
NOTICE OF ALLOWANCE CANCELLED
Apr 9, 2008 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Apr 9, 2008 D1BR
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 13, 2007 NOAM
PUBLISHED FOR OPPOSITION
Aug 21, 2007 PUBO
NOTICE OF PUBLICATION
Aug 1, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 19, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 16, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 16, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 16, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 16, 2007 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 16, 2007 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 10, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 10, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 10, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 10, 2007 CNEA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 9, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 9, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 9, 2007 CNEA
EXAMINER'S AMENDMENT ENTERED
Jul 5, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 5, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 5, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 5, 2007 CNEA
AMENDMENT FROM APPLICANT ENTERED
Jun 15, 2007 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2007 CRFA
ASSIGNED TO LIE
Jun 7, 2007 ALIE
PAPER RECEIVED
May 21, 2007 MAIL
NON-FINAL ACTION E-MAILED
Nov 27, 2006 GNRT
NON-FINAL ACTION WRITTEN
Nov 27, 2006 CNRT
AMENDMENT FROM APPLICANT ENTERED
Nov 3, 2006 ACEC
PAPER RECEIVED
Oct 10, 2006 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2006 CRFA
NON-FINAL ACTION E-MAILED
Apr 6, 2006 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2006 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2006 DOCK
AMENDMENT FROM APPLICANT ENTERED
Feb 16, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2006 CRFA
PAPER RECEIVED
Feb 2, 2006 MAIL
NEW APPLICATION ENTERED
Oct 4, 2005 NWAP